It was reported that the osteoprotegerin/nuclear factor κB receptor activator/nuclear factor κB receptor activator ligand (OPG/RANK/RANKL) signaling pathway and the osteopontin (OPN) system had essential involvement in bone metabolic abnormalities caused by MDD. Here, SPP1 is linked to major depressive disorder.